Sign In
Buy MCK
$763.91
+18.79 (+2.52%)
At Close: Jun 23, 2026
Thermo Fisher (TMO) Debuts Raman Spectroscopic Analyzer
01:35pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Thermo Fisher's (TMO) Ramina Process Analyzer allows users to conduct precise in situ Raman measurements in a simple manner with high accuracy.
Walgreens (WBA) Expands Medical Care Offerings in California
01:31pm, Thursday, 07'th Apr 2022 Zacks Investment Research
Walgreens' (WBA) new initiative is intended to reduce care gaps and advance care management by providing access to more affordable and convenient services.
5 Dividend Growth Stocks for Safe Income Amid Volatility
11:24am, Thursday, 07'th Apr 2022 Zacks Investment Research
The Kroger (KR), NVIDIA (NVDA), Jones Lang LaSalle (JLL), Paychex (PAYX) and McKesson (MCK) could be compelling picks amid market volatility.
5 Dividend Growth Stocks for Safe Income Amid Volatility
09:02am, Thursday, 07'th Apr 2022
The Kroger (KR), NVIDIA (NVDA), Jones Lang LaSalle (JLL), Paychex (PAYX) and McKesson (MCK) could be compelling picks amid market volatility.
Here's Why You Should Retain Cooper Companies (COO) Stock Now
02:49pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
Cooper Companies (COO) continues to benefit from strength in its business segments.
Bruker (BRKR) to Support Biopharma Industries With New Buyout
01:25pm, Wednesday, 06'th Apr 2022 Zacks Investment Research
Bruker's (BRKR) recent buyout strengthens the company as a key software and solutions provider for small molecule, biologics and new drug modalities pharma companies.
Why McKesson (MCK) is a Top Growth Stock for the Long-Term
02:47pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.
Here's Why You Should Retain Teleflex (TFX) Stock for Now
02:05pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Investors are optimistic about Teleflex (TFX) on increased UroLift demand and strong vascular business.
Medtronic (MDT) Reports Positive Findings Backing RDN System
01:30pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Medtronic's (MDT) Symplicity Spyral RDN system demonstrated durable and clinically significant reductions in blood pressure at the SPYRAL HTN-ON MED trial.
Medtronic (MDT) Innovations Aid Global Growth, Volume Woe Stays
01:09pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
In the neuroscience portfolio, Medtronic (/MDT) is gaining market share in Cranial and Spinal technologies.
Abbott (ABT) Aveir VR Leadless Pacemaker Receives FDA Nod
12:57pm, Tuesday, 05'th Apr 2022 Zacks Investment Research
Abbott's (ABT) Aveir VR is a leadless pacemaker designed to treat patients with slow heart rhythms in the United States.
Zimmer Biomet (ZBH) Hurt by China VBP, COVID-Led Staff Shortage
02:33pm, Monday, 04'th Apr 2022 Zacks Investment Research
Zimmer Biomet (ZBH) expects to face an adverse pricing impact in the first half of 2022, which is being compared to the non-VBP first half of 2021.
Here's Why You Should Retain AmerisourceBergen (ABC) Stock
01:59pm, Monday, 04'th Apr 2022 Zacks Investment Research
AmerisourceBergen (ABC) continues to gain traction from the robust U.S. Healthcare Solutions segment. However, stiff competition is a woe.
NextGen (NXGN) Introduces New Integrated Care EHR Solution
01:55pm, Monday, 04'th Apr 2022 Zacks Investment Research
NextGen's (NXGN) newest solution lends support to comprehensive primary care and behavioral health with intellectual and developmental disabilities.
Here's Why You Should Add Bruker (BRKR) Stock to Your Kitty
01:52pm, Monday, 04'th Apr 2022 Zacks Investment Research
Bruker's (BRKR) Nano Group microelectronics and semiconductor metrology tools continue to perform well on ongoing strength in bookings and backlog.
